Sector

Pharma & Biotech

Hong Kong IP Experts 2022

Hong Kong IP Experts 2022

30 April 2022

With China’s forthcoming Guangdong-Hong Kong-Macau Greater Bay Area well on its way to fruition, Hong Kong-based lawyers will continue to play a key role in the development of intellectual property in the region.

Patent waiver for Covid-19 vaccines finally approved

Patent waiver for Covid-19 vaccines finally approved

30 June 2022

The World Trade Organization (WTO) has finally approved the patent waiver that will tear down barriers mounted by intellectual property restrictions to greater production of Covid-19 vaccines and their equitable distribution among nations.

Biplab Lenin promoted to partner at Cyril Amarchand

Biplab Lenin promoted to partner at Cyril Amarchand

19 May 2022

Biplab Lenin promoted to partner at Cyril Amarchand

2022 IP Profiles Survey

2022 IP Profiles Survey

28 February 2022

In September, Asia IP will publish the 2022 edition of Asia IP Profiles. This guide is the definitive resource for companies trying to identify the best IP practices in the region, and is based on editorial research, and surveys submitted by leading...

Chatbots: A way to immortalize the dead?

Chatbots: A way to immortalize the dead?

28 February 2022

When Microsoft secured a patent for conversational chatbots to mine data from a person’s social media history, observers wondered how it might affect the person’s intellectual property rights

Brain interfacing, copyright and the patent system

Brain interfacing, copyright and the patent system

28 February 2022

Brain interfacing has been gaining traction since Elon Musk’s investment in Neuralink. Lawyers discuss how future brain-computer collaborations might affect copyright and patent laws.

The Winners of the Asia IP 2021 Awards

The Winners of the Asia IP 2021 Awards

17 January 2022

You have spoken. The verdict is in. And the winners are...

India’s IP Experts

India’s IP Experts

17 January 2022

We reveal India's leading IP Experts

Asia IP’s editorial team reveals India’s top IP firms, practices

Asia IP’s editorial team reveals India’s top IP firms, practices

30 November 2021

And the winners of the 2021 Asia IP India Awards are...

IPOPHL collaborates with the Pharmaceutical Security Institute to combat the rise of counterfeit pharmaceuticals

IPOPHL collaborates with the Pharmaceutical Security Institute to combat the rise of counterfeit pha...

30 November 2021

Taiwan's IP Experts

Taiwan's IP Experts

16 September 2021

The ayes and nays of ‘covered’ and ‘disclosed’ in a patent

The ayes and nays of ‘covered’ and ‘disclosed’ in a patent

31 August 2021

AstraZeneca AB filed an application at the Delhi High Court seeking an interim injunction for restraining Emcure Pharmaceuticals Ltd. from making, selling, distributing, exporting or offering for sale products comprising the compound Ticagrelor under...

Malaysia’s IP Experts

Malaysia’s IP Experts

31 August 2021

Asia IP reveals the top 50 IP Experts in Malaysia!

Patentability of inventions relating to dosing regimen in China

Patentability of inventions relating to dosing regimen in China

31 August 2021

Although methods for the diagnosis and treatment of diseases are not granted patent rights in China, the CNIPA will allow an applicant to seek protection for inventions relating to the second medical use of a substance. Jiancheng Jiang explains the i...

Number of IP Filings In The Philippines Increaes By 20% In First Half

Number of IP Filings In The Philippines Increaes By 20% In First Half

30 August 2021

The total number of IP applications was 22,919. The most significant rise was in utility model (UM) submissions, which increased by 26% from 592 to 744 between January and June of last year.

Please wait while the page is loading...

loader